Related Experiment Videos
Evidence of enhanced platelet aggregation and platelet sensitivity in migraine patients
Abstract:
In fourteen untreated migraine patients with a mean age of 40 years platelet sensitivity to 5HT, EN and ADP was investigated during the prodromal phase (three patients), 12-48 h after headache (three patients) and during the headache-free period (eight patients). Platelet sensitivity was tested using an optical density method and was calculated by the percentage of disaggregation (%DA) occurring 3 min after the peak aggregation. Platelet release reaction was assessed using beta-thromboglobulin (beta-TG) as an indicator. Platelet sensitivity to low concentrations of 5HT, EN and ADP (0.3 X 10(-9) M/ml) was most marked during the headache and prodromal phases. The least platelet sensitivity in migraineurs was detected during the headache-free interval, but was still higher than in the control group. beta-TG levels were increased during the headache phase indicating platelet release reaction. A general hyperaggregability of platelets in migraineurs has been demonstrated and in addition a varying sensibility of platelets to low concentrations of 5HT, EN and ADP has been established.
Insights
Migraine patients exhibit increased platelet sensitivity to serotonin (5HT), epinephrine (EN), and adenosine diphosphate (ADP), particularly during headache and prodromal phases. This heightened platelet reactivity, indicated by beta-thromboglobulin (beta-TG) levels, suggests a role in migraine pathophysiology.
Area of Science:
- Neuroscience
- Hematology
- Clinical Medicine
Background:
- Migraine is a complex neurological disorder often associated with vascular changes.
- Platelet activation and aggregation are implicated in various vascular events.
- Understanding platelet behavior in migraineurs is crucial for elucidating disease mechanisms.
Purpose of the Study:
- To investigate platelet sensitivity to specific agonists (5HT, EN, ADP) in untreated migraine patients.
- To assess platelet release reactions during different phases of the migraine cycle.
- To determine if altered platelet sensitivity correlates with migraine phases.
Main Methods:
- Optical density method used to measure platelet sensitivity (%DA) in 14 untreated migraine patients.
- Platelet sensitivity assessed during prodromal, post-headache, and headache-free periods.
- Beta-thromboglobulin (beta-TG) levels measured to indicate platelet release reaction.
Main Results:
- Platelet sensitivity to low concentrations of 5HT, EN, and ADP was highest during the prodromal and headache phases.
- Platelet sensitivity remained elevated during headache-free periods compared to controls.
- Increased beta-TG levels during the headache phase indicated platelet activation and release.
Conclusions:
- Migraineurs exhibit generalized platelet hyperaggregability.
- Platelet sensitivity to 5HT, EN, and ADP varies significantly across migraine phases.
- Altered platelet function, particularly heightened sensitivity to agonists, may contribute to migraine pathophysiology.